Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Neurosoft Bioelectronics SA

History from 28 Jul 2020

UID
CHE-325.358.554
Legal form
AG
Canton
GE
Founded
28 Jul 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 236k
66k132k198k263k7 Jun 2023 · CHF 104k4 Apr 2024 · CHF 119k10 Jun 2026 · CHF 263kRound announced 20 May 2026202420252026
  • shares
  • all shares
  • privilégiées quant au produit de liquidation
  • round announced

Record

  1. Company formed

    Founded 28 Jul 2020

    SHAB HR01-1004956682 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 104’000
    Shares
    10’000’000 → 10’400’000
    New shares, % of post-step shares
    3.8% (400’000 new)

    Augmentation ordinaire du capital-actions porté de CHF 100'000 à CHF 104'000 par l'émission de 400'000 actions de CHF 0.01, nominatives, liées selon statuts. Capital-actions: CHF 104'000, entièrement libéré, divisé en 10'400'000 actions de CHF 0.01, nominatives, liées selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005763266 ↗
  3. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    104’000 → 119’327.99
    Shares
    10’400’000 → 11’932’799
    New shares, % of post-step shares
    12.8% (1’532’799 new)
    Share classes
    10’400’000 × CHF 0.01 · 1’532’799 × CHF 0.01 privilégiées quant au produit de liquidation

    Capital-actions: CHF 119'327, 99, entièrement libéré, divisé en 10'400'000 actions ordinaires de CHF 0.01, et 1'532'799 actions de CHF 0.01, privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006001293 ↗
  4. Round announced

    matched to a capital increase · high match confidence

    Announcement ↗
  5. Capital increase

    Confirmed round · missed by classifier

    Paid by converting claims

    Nominal capital
    119’327.99 → 263’404.74
    Shares
    11’932’799 → 23’640’474
    New shares, % of post-step shares
    49.5% (11’707’675 new)
    Share classes
    10’400’000 × CHF 0.01 · 13’240’474 × CHF 0.01 privilégiées quant au produit de liquidation

    Augmentation ordinaire du capital-actions porté de CHF 119'327, 99 à CHF 263'404, 74 par l'émission de 11'707'675 actions de CHF 0.01, privilégiées quant au produit de liquidation, nominatives, liées selon statuts. Capital-actions: CHF 263'404, 74, entièrement libéré, divisé en 10'400'000 actions de CHF 0.01 et 13'240'474 actions de CHF 0.01, privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts. L'inscription no. 6445 du 28.03.2024 (publication FOSC du 04.04.2024, page 0/1006001293) est complétée en ce sens que l'assemblée générale a introduit une clause statutaire relative à une marge de fluctuation du capital-actions par décision du 29.02.2024. L'assemblée …

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • Paid entirely by converting existing claims, with no new money.−1.5

    Classifier score 0.20 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006673318 ↗
  6. Capital band adopted

    SHAB HR02-1006673318 ↗
  7. Capital reduction

    Payment not stated

    Nominal capital
    263’404.74 → 236’404.74
    Shares
    23’640’474 → —
    New shares, % of post-step shares
    — (capital reduction)

    L'inscription no. 14927 du 05.06.2026 est rectifiée en ce sens que le capital-actions est de CHF 236'404.74 (et non: 263'404.74).

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006680342 ↗

Published by 8 Oct 2026